Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

364
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
364
Healthcare Agencies II01:17

Healthcare Agencies II

743
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
743
Pharmacovigilance01:19

Pharmacovigilance

965
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
965
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

835
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
835
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-efficient machine learning approach for predicting asthma attack risk.

Scientific reports·2026
Same author

Fostering trust in digital respiratory medicine: the open access ERS CONNECT digital health technology repository.

The European respiratory journal·2026
Same author

Impact of Metformin on Healthspan-Related Outcomes and Incidence of Diseases of Aging in People with Type 2 Diabetes Mellitus: A Systematic Review.

Rejuvenation research·2026
Same author

Completeness of EMERGE guideline reporting in observational studies of PCSK9 inhibitor medication adherence: a study within a systematic review.

JBI evidence synthesis·2026
Same author

Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review.

Journal of medical Internet research·2026
Same author

New Zealand pharmacist prescribers: a descriptive study of roles and practice.

The International journal of pharmacy practice·2026

Related Experiment Video

Updated: Aug 30, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

A comparative analysis of pharmaceutical workforce development needs across the commonwealth.

Ian Bates1, Devang Patel2, Amy Hai Yan Chan3

  • 1UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK; International Pharmaceutical Federation, Andries Bickerweg 5, 2517, JP The Hague, the Netherlands.

Research in Social & Administrative Pharmacy : RSAP
|August 28, 2022
PubMed
Summary

Global pharmacy workforce development faces challenges. This study identifies key needs and assesses progress towards International Pharmaceutical Federation (FIP) goals across Commonwealth nations, highlighting disparities between high- and low-income countries.

Keywords:
Commonwealth pharmacyContinuing professional development (CPD)International pharmaceutical federation (FIP)Needs assessmentPharmacy workforce development

More Related Videos

Comprehensive Analysis of Drug Response using the FLICK Assay
09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

346
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.0K

Related Experiment Videos

Last Updated: Aug 30, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Comprehensive Analysis of Drug Response using the FLICK Assay
09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

346
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.0K

Area of Science:

  • Health Policy
  • Pharmacy Practice
  • Global Health

Background:

  • Global demographic shifts and increased medication use necessitate transformative health workforce policies.
  • The International Pharmaceutical Federation (FIP) developed 21 Global Development Goals (FIP DGs) to guide pharmacy workforce strengthening.
  • This research focuses on pharmacy workforce development within Commonwealth countries, examining progress on FIP DGs.

Approach:

  • A comprehensive literature review of relevant databases (PubMed/Medline, CINAHL, Scopus, PsychINFO) was conducted.
  • A global survey targeted professional leadership bodies in Commonwealth countries to assess alignment with FIP DGs.
  • Data from 21 Commonwealth countries were analyzed, including 31 literature articles and survey responses.

Key Points:

  • Identified pharmacy workforce needs include shortages, inequitable distribution, low supply capacity, feminization, lack of recognition, limited training, low job satisfaction, high workload, and attrition.
  • Significant disparities exist in country-level progress and alignment with FIP DGs, with high-income countries reporting greater alignment than low-income countries.
  • Most countries align with FIP DGs for academic capacity, early career training, quality assurance, and integrated services; fewer align with competency, leadership, equity, and equality goals.

Conclusions:

  • The study outlines realistic pharmacy workforce development needs across Commonwealth nations.
  • Addressing identified needs through targeted policy interventions is crucial for enhancing pharmacy workforce capacity.
  • Strengthening the pharmacy workforce is essential for ensuring high-quality pharmaceutical care and medication expertise globally.